Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Equity (2016 - 2025)

Historic Return on Equity for Sunshine Biopharma (SBFM) over the last 12 years, with Q3 2025 value amounting to 0.24%.

  • Sunshine Biopharma's Return on Equity fell 700.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.23% for FY2024, which is 200.0% down from last year.
  • Per Sunshine Biopharma's latest filing, its Return on Equity stood at 0.24% for Q3 2025, which was down 700.0% from 0.26% recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Return on Equity ranged from a high of 25.85% in Q4 2021 and a low of 1.33% during Q1 2023
  • Over the past 5 years, Sunshine Biopharma's median Return on Equity value was 0.21% (recorded in 2023), while the average stood at 2.44%.
  • As far as peak fluctuations go, Sunshine Biopharma's Return on Equity soared by 84200bps in 2021, and later plummeted by -267100bps in 2022.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Return on Equity stood at 25.85% in 2021, then plummeted by -103bps to 0.86% in 2022, then surged by 76bps to 0.21% in 2023, then decreased by -1bps to 0.21% in 2024, then fell by -14bps to 0.24% in 2025.
  • Its Return on Equity was 0.24% in Q3 2025, compared to 0.26% in Q2 2025 and 0.22% in Q1 2025.